Match each specific autoantibody profile with its most strongly associated clinical presentation or syndrome.
- Anti-histidyl-tRNA synthetase (Anti-Jo-1) antibodiesInflammatory myopathy, interstitial lung disease, and hyperkeratotic, fissured skin on the palmar and lateral surfaces of the fingers
- Anti-Ro/SSA antibodiesFetal bradycardia progressing to third-degree atrioventricular block in a neonate born to a mother with dry eyes and dry mouth
- Anti-U1 ribonucleoprotein (RNP) antibodiesA systemic autoimmune disease characterized by overlapping features of polymyositis, systemic sclerosis, and systemic lupus erythematosus
- Anti-centromere antibodiesLimited cutaneous systemic sclerosis with a highly elevated risk of developing isolated pulmonary arterial hypertension
Answer
Anti-Jo-1 matches with antisynthetase syndrome (myopathy, ILD, mechanic's hands). Anti-Ro/SSA matches with neonatal lupus (congenital heart block). Anti-U1 RNP matches with Mixed Connective Tissue Disease (overlap syndrome). Anti-centromere matches with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.
Each specific autoantibody strongly correlates with a distinct clinical syndrome. Anti-Jo-1 identifies patients with antisynthetase syndrome. Anti-Ro/SSA identifies mothers at risk of having infants with neonatal lupus and congenital heart block. Anti-U1 RNP is the defining marker for Mixed Connective Tissue Disease. Anti-centromere antibodies identify patients with limited cutaneous systemic sclerosis who are at high risk for isolated pulmonary arterial hypertension.
Step-by-Step Solution
Key Concept
Autoantibody profiles serve as critical diagnostic and prognostic markers for distinct rheumatologic syndromes, guiding both diagnosis and the screening for specific severe organ manifestations.